معرفی
Israel Safiriyu is a Research Fellow in the Department of Internal Medicine at Yale School of Medicine. He completed his MBChB at Olabisi Onabanjo University and residency/fellowship training at Albert Einstein College of Medicine/Jacobi Medical Center. Board-certified in Internal Medicine (ABIM 2022), he focuses on cardiovascular outcomes, interventional cardiology, and healthcare disparities. His research spans transcatheter valve therapies, pulmonary hypertension, and the impact of comorbidities like renal disease on cardiac interventions.
- Affiliations: Yale Cardiovascular Medicine Fellowship Program, New York City Health and Hospitals System
- Education: MBChB (Olabisi Onabanjo University), Residency/Jacobi Medical Center, Fellowship/Yale SOM
Research interests include device-associated complications (e.g., tricuspid regurgitation), pandemic impacts on cardiovascular care (e.g., pulmonary embolism outcomes during COVID-19), and disparities in access to procedures like TAVR and mitral clip repair. He has published 16 peer-reviewed articles since 2022.
Awards: Recognized for clinical teaching (Dr. Peggy Bia Award), patient safety, and excellence in medical education (Leo M. Davidoff Society).
Recent work emphasizes real-world outcomes of drug-coated devices in peripheral vascular disease and gender differences in Watchman device outcomes. His studies leverage nationwide datasets to address critical gaps in understanding cardiovascular disease patterns and treatment efficacy.
